CVS Group plc (LON:CVSG – Get Free Report) traded up 1.2% on Monday. The stock traded as high as GBX 1,379 and last traded at GBX 1,370. 389,990 shares traded hands during trading, a decline of 55% from the average session volume of 867,277 shares. The stock had previously closed at GBX 1,354.25.
Analyst Ratings Changes
A number of equities analysts recently issued reports on CVSG shares. Shore Capital Group reiterated a “hold” rating and issued a GBX 1,400 target price on shares of CVS Group in a report on Thursday, September 24th. Deutsche Bank reaffirmed a “buy” rating and set a GBX 1,700 price target on shares of CVS Group in a research report on Monday, July 27th. Berenberg Bank reissued a “buy” rating and set a GBX 2,000 price objective on shares of CVS Group in a report on Thursday, September 24th. Finally, Jefferies Financial Group reaffirmed a “hold” rating and issued a GBX 1,400 price target on shares of CVS Group in a report on Friday, September 25th. Four investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of GBX 1,666.67.
Check Out Our Latest Stock Report on CVS Group
CVS Group Price Performance
The business has a 50 day simple moving average of GBX 1,278.17 and a two-hundred day simple moving average of GBX 1,254.43. The firm has a market capitalization of £935.73 million, a P/E ratio of 57.74, a price-to-earnings-growth ratio of 1.77 and a beta of 1.07. The company has a debt-to-equity ratio of 110.41, a quick ratio of 0.90 and a current ratio of 1.18.
CVS Group (LON:CVSG – Get Free Report) last announced its earnings results on Thursday, September 24th. The company reported GBX 85.60 earnings per share (EPS) for the quarter. CVS Group had a net margin of 2.43% and a return on equity of 5.91%. On average, sell-side analysts expect that CVS Group plc will post 93.94 EPS for the current fiscal year.
CVS Group Company Profile
CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy. The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).
Further Reading
- Five stocks we like better than CVS Group
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.
